TrialAntimicrobial agents and chemotherapy2006

Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in healthy volunteers.

Anne Schmitt-Hoffmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.